Subsidiaries and holdings
- IZETOR33.33%
From the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette
Amerlynck has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €15,404 and a net result of €10,404. Its solvency ranks better than 23% of 39,242 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 70, micro). It does better than 23% of them on solvency, 30% on liquidity and 54% on profitability.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Show the recommended maximum and see how the verdict changes with amount, term and advance.
These companies have the same main activity as Amerlynck: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €68,600 and €93,500, founded in 2025.
| Company | Total assets | Gross margin |
|---|---|---|
| Amerlynck Kruisem | €78,911 | €13,986 |
| Gilvan Merelbeke-Melle | €68,561 | €13,063 |
| Pharmia Consult Evergem | €85,324 | €12,346 |
| Sytaco Herzele | €83,823 | €15,313 |
| Impact WITH Empathy Destelbergen | €93,542 | €16,551 |
| GENESIS CONSULTING Gerpinnes | €69,248 | €13,528 |
| ADM+ Vorst | €84,462 | €15,309 |
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.